SPL 0.00% 9.4¢ starpharma holdings limited

Ann: Half Yearly Report and Accounts, page-5

  1. 2,256 Posts.
    lightbulb Created with Sketch. 325
    I agree with your comments around the marketing of VIRALEZE.

    BUT the product needs to be approved before you can got out into the public and start marketing it.

    Further to that, unfortunately for us shareholders, marketing is not the responsibility of SPL, it is the distributors responsibility to market the product.

    Therein lies the major problem with SPL. We make these hugely hopeful announcements about these great partnership deals that we make and then cash in on the KPI bonuses, all the while these "partners" then just sit on our product and do not market it and therefore there is no sales revenue that comes back to SPL

    Without up front payments and ongoing commitments to marketing, our products will NEVER succeed.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.000(0.00%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $481 5.115K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 11.47am 09/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.